NASDAQ:BNTX

Biontech Se Sponsored Adr Stock Forecast

etoro logo Buy BNTX
*Your capital is at risk
$90.89
-1.33 (-1.44%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of BNTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BNTX to Watchlist?
Some Reasons Why To Add BNTX:
  • High gross margin of 77.6%
  • Low bankruptcy risk (Altman Z-Score: 6.81)
  • Mid-to-large cap with $23.3B market cap
PDF

Biontech Se Sponsored Adr stock downgraded from Buy Candidate to Hold/Accumulate after Thursday trading session
(Updated on Jun 18, 2026)

Buy or Hold candidate since Jun 17, 2026 Loss -1.44%

The Biontech Se Sponsored Adr stock price fell by -1.44% on the last day (Thursday, 18th Jun 2026) from $92.22 to $90.89. During the last trading day the stock fluctuated 3.34% from a day low at $90.12 to a day high of $93.13. The price has been going up and down for this period, and there has been a 1.45% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -23 thousand shares and in total, 878 thousand shares were bought and sold for approximately $79.80 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.00% during the next 3 months and, with a 90% probability hold a price between $82.52 and $106.12 at the end of this 3-month period.

BNTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 6.30%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biontech Se Sponsored Adr stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $91.78. On a fall, the stock will find some support from the short-term average at $89.95. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Biontech Se Sponsored Adr stock

Biontech Se Sponsored Adr finds support from accumulated volume at $89.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.01 between high and low, or 3.34%. For the last week, the stock has had daily average volatility of 2.61%.

Our recommended stop-loss: $86.61 (-4.71%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (BNTX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Biontech Se Sponsored Adr to open at $91.38, and during the day (based on 14 day Average True Range), to move between $89.44 and $92.34, which gives a possible trading interval of +/-$2.91 (+/-3.25%) up or down from last closing price. If Biontech Se Sponsored Adr takes out the full calculated possible swing range there will be an estimated 3.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $89.54 (1.49%) than the resistance at $95.50 (5.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Biontech Se Sponsored Adr stock A Buy?

Biontech Se Sponsored Adr holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.621 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $91.38 ( 0.539%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BNTX Performance

Trading levels for BNTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 94.39 3.85%
R2 93.24 2.59%
R1 92.53 1.80%
Price 90.89
S1 90.23 -0.726%
S2 89.52 -1.51%
S3 88.37 -2.77%

Accumulated Volume Support & Resistance Levels

Level Price
R3 111.60 22.79%
R2 102.06 12.29%
R1 95.50 5.07%
Price 90.89
S1 89.54 -1.49%
S2 89.31 -1.74%
S3 89.27 -1.78%

BNTX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 28, 2022 Jun 02, 2022 Jun 17, 2022 $2.11 1.69%

FAQ

What is the symbol for Biontech Se Sponsored Adr Stock and on which exchange is it traded?
The symbol for Biontech Se Sponsored Adr is BNTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Biontech Se Sponsored Adr Stock?
Biontech Se Sponsored Adr holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Biontech Se Sponsored Adr Stock?
Biontech Se Sponsored Adr Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biontech Se Sponsored Adr Stock.

What's the current price of Biontech Se Sponsored Adr Stock?
As of the end of day on the Jun 18, 2026, the price of an Biontech Se Sponsored Adr (BNTX) share was $90.89.

What is the 52-week high and low for Biontech Se Sponsored Adr Stock?
The 52-week high for Biontech Se Sponsored Adr Stock is $123.80 and the 52-week low is $79.52.

What is the market capitalization of Biontech Se Sponsored Adr Stock?
As of the Jun 18, 2026, the market capitalization of Biontech Se Sponsored Adr is 22.985B.

When is the next earnings date for Biontech Se Sponsored Adr?
The upcoming earnings date for Biontech Se Sponsored Adr is Aug 03, 2026.
Click to get the best stock tips daily for free!
ABOUT BIONTECH SE SPONSORED ADR
Biontech Se Sponsored Adr
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for tripl...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE